Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.
On Tuesday, Dimension Therapeutics (DMTX)'s Director, Michael Dybbs, made a $12.5M purchase of DMTX, buying 961,538 shares at a cost of $13.00 a piece. Bargain hunters are able to bag DMTX even cheaper than Dybbs did, with shares changing hands as low as $12.45 at last check today -- that's 4.3% below Dybbs's purchase price. Dimension Therapeutics is trading off about 0.3% on the day Friday. This purchase marks the first one filed by Dybbs in the past year.
And at Hancock Holding (HBHC), there was insider buying on Wednesday, by George A. Schloegel who bought 4,000 shares for a cost of $27.48 each, for a total investment of $109,920. Before this latest buy, Schloegel made one other purchase in the past twelve months, buying $105,233 shares at a cost of $26.31 a piece. Hancock Holding is trading off about 0.6% on the day Friday. Schloegel was up about 2.2% on the buy at the high point of today's trading session, with HBHC trading as high as $28.09 in trading on Friday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.